Synthesis and structure-activity analysis of new phosphonium salts with potent activity against African trypanosomes

Andrea Taladriz, Alan Healy, Eddysson J. Flores Pérez, Vanessa Herrero García, Carlos Ríos Martínez, Abdulsalam A.M. Alkhaldi, Anthonius A. Eze, Marcel Kaiser, Harry P. De Koning, Antonio Chana, Christophe Dardonville

Research output: Contribution to journalArticle

Abstract

A series of 73 bisphosphonium salts and 10 monophosphonium salt derivatives were synthesized and tested in vitro against several wild type and resistant lines of Trypanosoma brucei (T. b. rhodesiense STIB900, T. b. brucei strain 427, TbAT1-KO, and TbB48). More than half of the compounds tested showed a submicromolar EC 50 against these parasites. The compounds did not display any cross-resistance to existing diamidine therapies, such as pentamidine. In most cases, the compounds displayed a good selectivity index versus human cell lines. None of the known T. b. brucei drug transporters were required for trypanocidal activity, although some of the bisphosphonium compounds inhibited the low affinity pentamidine transporter. It was found that phosphonium drugs act slowly to clear a trypanosome population but that only a short exposure time is needed for irreversible damage to the cells. A comparative molecular field analysis model (CoMFA) was generated to gain insights into the SAR of this class of compounds, identifying key features for trypanocidal activity.

Original languageEnglish (US)
Pages (from-to)2606-2622
Number of pages17
JournalJournal of Medicinal Chemistry
Volume55
Issue number6
DOIs
StatePublished - Mar 22 2012

Fingerprint

Pentamidine
Trypanosomiasis
Salts
Trypanosoma brucei brucei
Pharmaceutical Preparations
Parasites
Cell Line
Population
Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Taladriz, A., Healy, A., Flores Pérez, E. J., Herrero García, V., Ríos Martínez, C., Alkhaldi, A. A. M., ... Dardonville, C. (2012). Synthesis and structure-activity analysis of new phosphonium salts with potent activity against African trypanosomes. Journal of Medicinal Chemistry, 55(6), 2606-2622. https://doi.org/10.1021/jm2014259

Synthesis and structure-activity analysis of new phosphonium salts with potent activity against African trypanosomes. / Taladriz, Andrea; Healy, Alan; Flores Pérez, Eddysson J.; Herrero García, Vanessa; Ríos Martínez, Carlos; Alkhaldi, Abdulsalam A.M.; Eze, Anthonius A.; Kaiser, Marcel; De Koning, Harry P.; Chana, Antonio; Dardonville, Christophe.

In: Journal of Medicinal Chemistry, Vol. 55, No. 6, 22.03.2012, p. 2606-2622.

Research output: Contribution to journalArticle

Taladriz, A, Healy, A, Flores Pérez, EJ, Herrero García, V, Ríos Martínez, C, Alkhaldi, AAM, Eze, AA, Kaiser, M, De Koning, HP, Chana, A & Dardonville, C 2012, 'Synthesis and structure-activity analysis of new phosphonium salts with potent activity against African trypanosomes', Journal of Medicinal Chemistry, vol. 55, no. 6, pp. 2606-2622. https://doi.org/10.1021/jm2014259
Taladriz, Andrea ; Healy, Alan ; Flores Pérez, Eddysson J. ; Herrero García, Vanessa ; Ríos Martínez, Carlos ; Alkhaldi, Abdulsalam A.M. ; Eze, Anthonius A. ; Kaiser, Marcel ; De Koning, Harry P. ; Chana, Antonio ; Dardonville, Christophe. / Synthesis and structure-activity analysis of new phosphonium salts with potent activity against African trypanosomes. In: Journal of Medicinal Chemistry. 2012 ; Vol. 55, No. 6. pp. 2606-2622.
@article{d1154597ee2e4f25a079a35008182c5d,
title = "Synthesis and structure-activity analysis of new phosphonium salts with potent activity against African trypanosomes",
abstract = "A series of 73 bisphosphonium salts and 10 monophosphonium salt derivatives were synthesized and tested in vitro against several wild type and resistant lines of Trypanosoma brucei (T. b. rhodesiense STIB900, T. b. brucei strain 427, TbAT1-KO, and TbB48). More than half of the compounds tested showed a submicromolar EC 50 against these parasites. The compounds did not display any cross-resistance to existing diamidine therapies, such as pentamidine. In most cases, the compounds displayed a good selectivity index versus human cell lines. None of the known T. b. brucei drug transporters were required for trypanocidal activity, although some of the bisphosphonium compounds inhibited the low affinity pentamidine transporter. It was found that phosphonium drugs act slowly to clear a trypanosome population but that only a short exposure time is needed for irreversible damage to the cells. A comparative molecular field analysis model (CoMFA) was generated to gain insights into the SAR of this class of compounds, identifying key features for trypanocidal activity.",
author = "Andrea Taladriz and Alan Healy and {Flores P{\'e}rez}, {Eddysson J.} and {Herrero Garc{\'i}a}, Vanessa and {R{\'i}os Mart{\'i}nez}, Carlos and Alkhaldi, {Abdulsalam A.M.} and Eze, {Anthonius A.} and Marcel Kaiser and {De Koning}, {Harry P.} and Antonio Chana and Christophe Dardonville",
year = "2012",
month = "3",
day = "22",
doi = "10.1021/jm2014259",
language = "English (US)",
volume = "55",
pages = "2606--2622",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "6",

}

TY - JOUR

T1 - Synthesis and structure-activity analysis of new phosphonium salts with potent activity against African trypanosomes

AU - Taladriz, Andrea

AU - Healy, Alan

AU - Flores Pérez, Eddysson J.

AU - Herrero García, Vanessa

AU - Ríos Martínez, Carlos

AU - Alkhaldi, Abdulsalam A.M.

AU - Eze, Anthonius A.

AU - Kaiser, Marcel

AU - De Koning, Harry P.

AU - Chana, Antonio

AU - Dardonville, Christophe

PY - 2012/3/22

Y1 - 2012/3/22

N2 - A series of 73 bisphosphonium salts and 10 monophosphonium salt derivatives were synthesized and tested in vitro against several wild type and resistant lines of Trypanosoma brucei (T. b. rhodesiense STIB900, T. b. brucei strain 427, TbAT1-KO, and TbB48). More than half of the compounds tested showed a submicromolar EC 50 against these parasites. The compounds did not display any cross-resistance to existing diamidine therapies, such as pentamidine. In most cases, the compounds displayed a good selectivity index versus human cell lines. None of the known T. b. brucei drug transporters were required for trypanocidal activity, although some of the bisphosphonium compounds inhibited the low affinity pentamidine transporter. It was found that phosphonium drugs act slowly to clear a trypanosome population but that only a short exposure time is needed for irreversible damage to the cells. A comparative molecular field analysis model (CoMFA) was generated to gain insights into the SAR of this class of compounds, identifying key features for trypanocidal activity.

AB - A series of 73 bisphosphonium salts and 10 monophosphonium salt derivatives were synthesized and tested in vitro against several wild type and resistant lines of Trypanosoma brucei (T. b. rhodesiense STIB900, T. b. brucei strain 427, TbAT1-KO, and TbB48). More than half of the compounds tested showed a submicromolar EC 50 against these parasites. The compounds did not display any cross-resistance to existing diamidine therapies, such as pentamidine. In most cases, the compounds displayed a good selectivity index versus human cell lines. None of the known T. b. brucei drug transporters were required for trypanocidal activity, although some of the bisphosphonium compounds inhibited the low affinity pentamidine transporter. It was found that phosphonium drugs act slowly to clear a trypanosome population but that only a short exposure time is needed for irreversible damage to the cells. A comparative molecular field analysis model (CoMFA) was generated to gain insights into the SAR of this class of compounds, identifying key features for trypanocidal activity.

UR - http://www.scopus.com/inward/record.url?scp=84858720242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858720242&partnerID=8YFLogxK

U2 - 10.1021/jm2014259

DO - 10.1021/jm2014259

M3 - Article

C2 - 22390399

AN - SCOPUS:84858720242

VL - 55

SP - 2606

EP - 2622

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 6

ER -